Content about Alex Gorsky

January 21, 2014

Johnson & Johnson cited the strength of key brands in its U.S. over-the-counter business as one of the driving factors that led to what chairman and CEO Alex Gorsky called “outstanding” results for the fourth quarter.

Johnson & Johnson cited the strength of key brands in its U.S. over-the-counter business as one of the driving factors that led to what chairman and CEO Alex Gorsky called “outstanding” results for the fourth quarter.

The company reported sales of $18.4 billion for the quarter, an increase of 4.5% as compared to the prior-year quarter. Operational results increased 6.3%. Domestic sales increased 7.4%, while international sales increased 2.4%, reflecting operational growth of 5.6%.

April 29, 2013

Johnson & Johnson chairman and CEO Alex Gorsky told shareholders at the company's annual shareholder meeting that its consumer healthcare business would reclaim its prominence in the U.S. marketplace. But OTC growth will be greatest outside of the U.S.

NEW BRUNSWICK, N.J. — Johnson & Johnson chairman and CEO Alex Gorsky told shareholders at the company's annual shareholder meeting that its consumer healthcare business would reclaim its prominence in the U.S. marketplace. But OTC growth will be greatest outside of the U.S.
 

November 30, 2012

Johnson & Johnson has elected Alex Gorsky as its new chairman, board of directors, effective December 28. Gorsky, who was appointed CEO in April of this year, replaces current chairman Bill Weldon, who was with the company for 41 years.

NEW BRUNSWICK, N.J. — Johnson & Johnson has elected Alex Gorsky as its new chairman, board of directors, effective December 28. Gorsky, who was appointed CEO in April of this year, replaces current chairman Bill Weldon, who was with the company for 41 years.